| Canada exports to China · Acyclic amides (including acyclic carbamates) and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Acyclic amides (including acyclic carbamates) and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Imides and their derivatives: other kinds, excluding saccharin | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Imines and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Nitrile-function compounds: n.e.s. in heading no. 2926 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Diazo-, azo- or azoxy compounds | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Organic derivatives of hydrazine or of hydroxylamine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Malaysia · Nitrogen-function compounds: n.e.s. in chapter 29, isocyanates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Nitrogen-function compounds: n.e.s. in chapter 29, isocyanates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Nitrogen-function compounds: n.e.s. in chapter 29, excluding isocyanates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Organo-sulphur compounds: thiocarbamates and dithiocarbamates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Finland · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Netherlands · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: n.e.s. in heading no. 2932 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than those of item no. 2933.11 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Italy · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing a benzothiazole ring-system (whether or not hydrogenated), not further fused | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Colombia · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Italy · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Rep. of Korea · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Sulphonamides | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: vitamins A and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: vitamin C and its derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: vitamin E and its derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Hong Kong SAR · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Hong Kong SAR · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Other Asia, nes · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Hormones and steroids used primarily as hormones: oestrogens and progestogens | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Hormones and steroids used primarily as hormones: (other than insulin and its salts, oestrogens and progestogens) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Sugars: chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers and sugar esters, and their salts, other than products of heading no. 2937, 2938 or 2939 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Sugars: chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers and sugar esters, and their salts, other than products of heading no. 2937, 2938 or 2939 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Antibiotics: penicillins and their derivatives with a penicillanic acid structure: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Antibiotics: n.e.s. in heading no. 2941 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Antibiotics: n.e.s. in heading no. 2941 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Antibiotics: n.e.s. in heading no. 2941 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Trinidad and Tobago · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Organic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Glands: extracts of glands, other organs or of their secretions, for organo-therapeutic uses | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Colombia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Czechia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Argentina · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Austria · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Rep. of Korea · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Malaysia · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Netherlands · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Pakistan · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
Research Data